

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.20539694 |
| 2 | vocalization behavior (GO:0071625) | 6.08382298 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.91055646 |
| 4 | neuron cell-cell adhesion (GO:0007158) | 5.55307900 |
| 5 | glutamate secretion (GO:0014047) | 5.41742742 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.39317746 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.33349397 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.26634997 |
| 9 | locomotory exploration behavior (GO:0035641) | 5.13555665 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.13156573 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.85330798 |
| 12 | neurotransmitter secretion (GO:0007269) | 4.82857825 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.82809450 |
| 14 | protein localization to synapse (GO:0035418) | 4.76451301 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.62277017 |
| 16 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.51975441 |
| 17 | exploration behavior (GO:0035640) | 4.46532075 |
| 18 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.37283672 |
| 19 | gamma-aminobutyric acid transport (GO:0015812) | 4.34225703 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.34058511 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.33585141 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.24826889 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 4.20805512 |
| 24 | layer formation in cerebral cortex (GO:0021819) | 4.18120213 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.16642953 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.13441612 |
| 27 | neurotransmitter transport (GO:0006836) | 4.06229724 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 4.04349827 |
| 29 | nucleobase catabolic process (GO:0046113) | 4.03086693 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.02631521 |
| 31 | proline transport (GO:0015824) | 4.02044317 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 4.00209080 |
| 33 | neuron recognition (GO:0008038) | 3.93284904 |
| 34 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.91250660 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 3.86179504 |
| 36 | regulation of neurotransmitter levels (GO:0001505) | 3.80801967 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.78323542 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.74563986 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.74502077 |
| 40 | long-term memory (GO:0007616) | 3.73508381 |
| 41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.69208180 |
| 42 | transmission of nerve impulse (GO:0019226) | 3.65517800 |
| 43 | prepulse inhibition (GO:0060134) | 3.64411995 |
| 44 | positive regulation of synapse maturation (GO:0090129) | 3.64277278 |
| 45 | positive regulation of membrane potential (GO:0045838) | 3.58712281 |
| 46 | mating behavior (GO:0007617) | 3.58705303 |
| 47 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.57434359 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57107922 |
| 49 | regulation of postsynaptic membrane potential (GO:0060078) | 3.56822980 |
| 50 | cerebellar granule cell differentiation (GO:0021707) | 3.54117056 |
| 51 | response to histamine (GO:0034776) | 3.53132451 |
| 52 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.43492051 |
| 53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.42956537 |
| 54 | postsynaptic membrane organization (GO:0001941) | 3.42506979 |
| 55 | regulation of vesicle fusion (GO:0031338) | 3.41490894 |
| 56 | axonal fasciculation (GO:0007413) | 3.41148783 |
| 57 | auditory behavior (GO:0031223) | 3.40267207 |
| 58 | establishment of mitochondrion localization (GO:0051654) | 3.40192877 |
| 59 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.39819258 |
| 60 | synapse assembly (GO:0007416) | 3.39690148 |
| 61 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.38779501 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 3.37862819 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 3.34360326 |
| 64 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.34169798 |
| 65 | activation of protein kinase A activity (GO:0034199) | 3.32572745 |
| 66 | presynaptic membrane assembly (GO:0097105) | 3.29705375 |
| 67 | regulation of synaptic plasticity (GO:0048167) | 3.29571493 |
| 68 | regulation of neurotransmitter secretion (GO:0046928) | 3.28585950 |
| 69 | response to auditory stimulus (GO:0010996) | 3.28502750 |
| 70 | intraspecies interaction between organisms (GO:0051703) | 3.26117127 |
| 71 | social behavior (GO:0035176) | 3.26117127 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.23482142 |
| 73 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.23289478 |
| 74 | detection of calcium ion (GO:0005513) | 3.23155842 |
| 75 | membrane hyperpolarization (GO:0060081) | 3.22809640 |
| 76 | striatum development (GO:0021756) | 3.18064988 |
| 77 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.18030324 |
| 78 | membrane depolarization (GO:0051899) | 3.16798879 |
| 79 | behavioral response to cocaine (GO:0048148) | 3.15327426 |
| 80 | regulation of neurotransmitter transport (GO:0051588) | 3.14189186 |
| 81 | startle response (GO:0001964) | 3.12156958 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 3.12068338 |
| 83 | neuromuscular synaptic transmission (GO:0007274) | 3.10858364 |
| 84 | serotonin metabolic process (GO:0042428) | 3.10836274 |
| 85 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.10357265 |
| 86 | learning (GO:0007612) | 3.09894497 |
| 87 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.08600282 |
| 88 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.06391363 |
| 89 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.05891559 |
| 90 | synaptic vesicle transport (GO:0048489) | 3.05862888 |
| 91 | establishment of synaptic vesicle localization (GO:0097480) | 3.05862888 |
| 92 | synaptic transmission (GO:0007268) | 3.05853519 |
| 93 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.04561416 |
| 94 | positive regulation of neurotransmitter transport (GO:0051590) | 3.04339439 |
| 95 | positive regulation of synapse assembly (GO:0051965) | 3.04308739 |
| 96 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.04272019 |
| 97 | dopamine biosynthetic process (GO:0042416) | 3.04181649 |
| 98 | presynaptic membrane organization (GO:0097090) | 3.04013572 |
| 99 | mechanosensory behavior (GO:0007638) | 3.03020565 |
| 100 | membrane depolarization during action potential (GO:0086010) | 3.02937218 |
| 101 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.02892026 |
| 102 | innervation (GO:0060384) | 3.02236718 |
| 103 | dendrite morphogenesis (GO:0048813) | 3.01438057 |
| 104 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.01191265 |
| 105 | positive regulation of dendritic spine development (GO:0060999) | 3.01026405 |
| 106 | response to amphetamine (GO:0001975) | 3.00353299 |
| 107 | catecholamine transport (GO:0051937) | 2.99133187 |
| 108 | cell migration in hindbrain (GO:0021535) | 2.98474959 |
| 109 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.98342664 |
| 110 | potassium ion homeostasis (GO:0055075) | 2.98039709 |
| 111 | vesicle transport along microtubule (GO:0047496) | 2.97460730 |
| 112 | regulation of synapse maturation (GO:0090128) | 2.97051977 |
| 113 | synapse organization (GO:0050808) | 2.96623008 |
| 114 | neuronal action potential (GO:0019228) | 2.95753240 |
| 115 | sodium ion export (GO:0071436) | 2.92747921 |
| 116 | neuromuscular process controlling balance (GO:0050885) | 2.92411611 |
| 117 | neuronal ion channel clustering (GO:0045161) | 2.92152945 |
| 118 | positive regulation of synaptic transmission (GO:0050806) | 2.91374548 |
| 119 | dendritic spine organization (GO:0097061) | 2.91162607 |
| 120 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.90749383 |
| 121 | mitochondrion transport along microtubule (GO:0047497) | 2.90749383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.41276894 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.80073073 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19750171 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08929437 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07055564 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74330640 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65071232 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65071232 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63686761 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58236204 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52193173 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50204553 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49608572 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46251708 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45555844 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.30675496 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.29891799 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27271443 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.25711111 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24417175 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22707340 |
| 22 | * TAF15_26573619_Chip-Seq_HEK293_Human | 2.21942491 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.20357410 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17191494 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11143390 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10656264 |
| 27 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.09451370 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.07686692 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91487025 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89266085 |
| 31 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.88279381 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.78071927 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77733038 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71038662 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62670946 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60753469 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.59191117 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57408184 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57278594 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54960461 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51015890 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45260692 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45090556 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41423348 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41048808 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40172323 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39727478 |
| 48 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37329459 |
| 49 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37150669 |
| 50 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37047008 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36708562 |
| 52 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36421101 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35288347 |
| 54 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34717608 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33471059 |
| 56 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.31351826 |
| 57 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29802279 |
| 58 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29593093 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28600916 |
| 60 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28015773 |
| 61 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26904959 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.26707792 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26262153 |
| 64 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.24355800 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19849489 |
| 66 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.17406720 |
| 67 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16657706 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14889711 |
| 69 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14302074 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13589358 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11757890 |
| 72 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10402653 |
| 73 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.10291007 |
| 74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08519669 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08028463 |
| 76 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07867174 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06848175 |
| 78 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05195108 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03826150 |
| 80 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03615469 |
| 81 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03309282 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03185738 |
| 83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02887196 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01653960 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01607444 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01548302 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01498138 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00910737 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00595658 |
| 90 | * JUN_21703547_ChIP-Seq_K562_Human | 1.00499035 |
| 91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98434526 |
| 92 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97481063 |
| 93 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97210484 |
| 94 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.96918099 |
| 95 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.96286400 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96070673 |
| 97 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.96032353 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94961620 |
| 99 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94046852 |
| 100 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.92390638 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92235922 |
| 102 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92125955 |
| 103 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92088876 |
| 104 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91681368 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91585258 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91585258 |
| 107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91021023 |
| 108 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89487531 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89237193 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86610458 |
| 111 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83947854 |
| 112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82941603 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82039332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.76630476 |
| 2 | MP0003880_abnormal_central_pattern | 5.44863076 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.07017315 |
| 4 | MP0009745_abnormal_behavioral_response | 3.43825347 |
| 5 | MP0009046_muscle_twitch | 3.35652274 |
| 6 | MP0004270_analgesia | 3.26522640 |
| 7 | MP0002822_catalepsy | 3.22494118 |
| 8 | MP0002064_seizures | 3.22364642 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.19943069 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.00118045 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.91939686 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.82621697 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.66669611 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.62332935 |
| 15 | MP0002272_abnormal_nervous_system | 2.57851998 |
| 16 | MP0001486_abnormal_startle_reflex | 2.51116144 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.45382544 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.34235477 |
| 19 | MP0002736_abnormal_nociception_after | 2.31947528 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.20764144 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.19641782 |
| 22 | MP0001529_abnormal_vocalization | 2.13971871 |
| 23 | MP0001970_abnormal_pain_threshold | 2.04643646 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.04558943 |
| 25 | MP0005386_behavior/neurological_phenoty | 1.97083210 |
| 26 | MP0004924_abnormal_behavior | 1.97083210 |
| 27 | MP0001905_abnormal_dopamine_level | 1.93583749 |
| 28 | MP0002184_abnormal_innervation | 1.90994489 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.85908767 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.81456049 |
| 31 | MP0003122_maternal_imprinting | 1.79135049 |
| 32 | MP0000778_abnormal_nervous_system | 1.78456515 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.76749091 |
| 34 | MP0003329_amyloid_beta_deposits | 1.69354904 |
| 35 | MP0008569_lethality_at_weaning | 1.69077456 |
| 36 | MP0001984_abnormal_olfaction | 1.68396385 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.66719249 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.61493226 |
| 39 | MP0004858_abnormal_nervous_system | 1.55302240 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.54880516 |
| 41 | MP0001188_hyperpigmentation | 1.54352303 |
| 42 | MP0000955_abnormal_spinal_cord | 1.45209351 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.41830624 |
| 44 | MP0003787_abnormal_imprinting | 1.41122302 |
| 45 | MP0004142_abnormal_muscle_tone | 1.39136423 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.36611403 |
| 47 | MP0003879_abnormal_hair_cell | 1.34301854 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.33604858 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.23242104 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.22937599 |
| 51 | MP0008872_abnormal_physiological_respon | 1.19250781 |
| 52 | MP0003633_abnormal_nervous_system | 1.15437700 |
| 53 | MP0004885_abnormal_endolymph | 1.12192480 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.09865456 |
| 55 | MP0002152_abnormal_brain_morphology | 1.06893388 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.05348638 |
| 57 | MP0003631_nervous_system_phenotype | 1.04191670 |
| 58 | MP0000751_myopathy | 1.02820357 |
| 59 | MP0004742_abnormal_vestibular_system | 0.95189729 |
| 60 | MP0005535_abnormal_body_temperature | 0.95075679 |
| 61 | MP0002069_abnormal_eating/drinking_beha | 0.92896657 |
| 62 | MP0002229_neurodegeneration | 0.92749303 |
| 63 | MP0005187_abnormal_penis_morphology | 0.92349649 |
| 64 | MP0002638_abnormal_pupillary_reflex | 0.91055868 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.90292062 |
| 66 | MP0008874_decreased_physiological_sensi | 0.87229819 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 0.86743915 |
| 68 | MP0005409_darkened_coat_color | 0.86533543 |
| 69 | MP0000013_abnormal_adipose_tissue | 0.82664933 |
| 70 | MP0005499_abnormal_olfactory_system | 0.82502605 |
| 71 | MP0005394_taste/olfaction_phenotype | 0.82502605 |
| 72 | MP0001177_atelectasis | 0.82139548 |
| 73 | MP0004085_abnormal_heartbeat | 0.82005606 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 0.80501122 |
| 75 | MP0001963_abnormal_hearing_physiology | 0.80298905 |
| 76 | MP0004145_abnormal_muscle_electrophysio | 0.79793105 |
| 77 | MP0003632_abnormal_nervous_system | 0.79549827 |
| 78 | MP0004133_heterotaxia | 0.79201096 |
| 79 | MP0001485_abnormal_pinna_reflex | 0.76906976 |
| 80 | MP0005253_abnormal_eye_physiology | 0.75890787 |
| 81 | MP0002752_abnormal_somatic_nervous | 0.75643185 |
| 82 | MP0001664_abnormal_digestion | 0.75361888 |
| 83 | MP0003634_abnormal_glial_cell | 0.74911869 |
| 84 | MP0002090_abnormal_vision | 0.71965985 |
| 85 | MP0004147_increased_porphyrin_level | 0.71617766 |
| 86 | MP0000604_amyloidosis | 0.70326478 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.68703902 |
| 88 | MP0002102_abnormal_ear_morphology | 0.67953580 |
| 89 | MP0004215_abnormal_myocardial_fiber | 0.67608488 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.67032540 |
| 91 | MP0000566_synostosis | 0.66366332 |
| 92 | MP0003690_abnormal_glial_cell | 0.65156742 |
| 93 | MP0001944_abnormal_pancreas_morphology | 0.62949878 |
| 94 | MP0000026_abnormal_inner_ear | 0.61213789 |
| 95 | MP0004484_altered_response_of | 0.61166335 |
| 96 | MP0003283_abnormal_digestive_organ | 0.60542168 |
| 97 | MP0003137_abnormal_impulse_conducting | 0.60540892 |
| 98 | MP0001943_abnormal_respiration | 0.60486729 |
| 99 | MP0003121_genomic_imprinting | 0.58643332 |
| 100 | MP0003890_abnormal_embryonic-extraembry | 0.58285042 |
| 101 | MP0004043_abnormal_pH_regulation | 0.57997250 |
| 102 | MP0003119_abnormal_digestive_system | 0.55566855 |
| 103 | MP0000920_abnormal_myelination | 0.55182817 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.54028147 |
| 105 | MP0010770_preweaning_lethality | 0.53685299 |
| 106 | MP0002082_postnatal_lethality | 0.53685299 |
| 107 | MP0010769_abnormal_survival | 0.52686407 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.52489270 |
| 109 | MP0005623_abnormal_meninges_morphology | 0.52222936 |
| 110 | MP0003861_abnormal_nervous_system | 0.52120920 |
| 111 | MP0003123_paternal_imprinting | 0.50922882 |
| 112 | MP0003956_abnormal_body_size | 0.50224824 |
| 113 | MP0010768_mortality/aging | 0.49428998 |
| 114 | MP0004233_abnormal_muscle_weight | 0.48587308 |
| 115 | MP0002751_abnormal_autonomic_nervous | 0.48536488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.73152351 |
| 2 | Myokymia (HP:0002411) | 6.03825932 |
| 3 | Focal seizures (HP:0007359) | 5.84696489 |
| 4 | Visual hallucinations (HP:0002367) | 5.26062858 |
| 5 | Atonic seizures (HP:0010819) | 4.84951482 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.73141746 |
| 7 | Febrile seizures (HP:0002373) | 4.58641723 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.57089525 |
| 9 | Limb dystonia (HP:0002451) | 4.56029147 |
| 10 | Absence seizures (HP:0002121) | 4.25540557 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.98239658 |
| 12 | Dialeptic seizures (HP:0011146) | 3.87467089 |
| 13 | Hyperventilation (HP:0002883) | 3.64730940 |
| 14 | Broad-based gait (HP:0002136) | 3.62159948 |
| 15 | Progressive inability to walk (HP:0002505) | 3.59897835 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.56512043 |
| 17 | Action tremor (HP:0002345) | 3.28428649 |
| 18 | Pheochromocytoma (HP:0002666) | 3.26415764 |
| 19 | Ankle clonus (HP:0011448) | 3.16932442 |
| 20 | Mutism (HP:0002300) | 3.16434578 |
| 21 | Papilledema (HP:0001085) | 3.13283770 |
| 22 | Poor eye contact (HP:0000817) | 3.11852837 |
| 23 | Depression (HP:0000716) | 3.10689342 |
| 24 | Truncal ataxia (HP:0002078) | 3.09465093 |
| 25 | Anxiety (HP:0000739) | 3.05781219 |
| 26 | Abnormal eating behavior (HP:0100738) | 3.05468380 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 3.05017547 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.99537669 |
| 29 | Abnormal social behavior (HP:0012433) | 2.96833079 |
| 30 | Impaired social interactions (HP:0000735) | 2.96833079 |
| 31 | Dysdiadochokinesis (HP:0002075) | 2.94173591 |
| 32 | Neuroendocrine neoplasm (HP:0100634) | 2.87385852 |
| 33 | Amblyopia (HP:0000646) | 2.85374296 |
| 34 | Drooling (HP:0002307) | 2.83125681 |
| 35 | Excessive salivation (HP:0003781) | 2.83125681 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83029851 |
| 37 | Polyphagia (HP:0002591) | 2.80570939 |
| 38 | Dysmetria (HP:0001310) | 2.76870290 |
| 39 | Cerebral inclusion bodies (HP:0100314) | 2.73368793 |
| 40 | Postural instability (HP:0002172) | 2.71821242 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.65982598 |
| 42 | Failure to thrive in infancy (HP:0001531) | 2.59797529 |
| 43 | Bradykinesia (HP:0002067) | 2.58923106 |
| 44 | Inability to walk (HP:0002540) | 2.57400005 |
| 45 | Epileptiform EEG discharges (HP:0011182) | 2.57148011 |
| 46 | Diplopia (HP:0000651) | 2.55526248 |
| 47 | Abnormality of binocular vision (HP:0011514) | 2.55526248 |
| 48 | Genetic anticipation (HP:0003743) | 2.53665986 |
| 49 | Fetal akinesia sequence (HP:0001989) | 2.53167388 |
| 50 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49092424 |
| 51 | Hemiparesis (HP:0001269) | 2.47021639 |
| 52 | Urinary urgency (HP:0000012) | 2.46797297 |
| 53 | Insidious onset (HP:0003587) | 2.42673334 |
| 54 | Termporal pattern (HP:0011008) | 2.42673334 |
| 55 | Spastic gait (HP:0002064) | 2.42350903 |
| 56 | Agitation (HP:0000713) | 2.42126238 |
| 57 | Sleep apnea (HP:0010535) | 2.40131307 |
| 58 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.39663937 |
| 59 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.39663937 |
| 60 | Torticollis (HP:0000473) | 2.38324834 |
| 61 | Absent speech (HP:0001344) | 2.37263043 |
| 62 | Hypsarrhythmia (HP:0002521) | 2.36740087 |
| 63 | Abnormality of the corticospinal tract (HP:0002492) | 2.33485498 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.32481328 |
| 65 | Focal dystonia (HP:0004373) | 2.30554591 |
| 66 | Muscular hypotonia of the trunk (HP:0008936) | 2.28424168 |
| 67 | Hypoventilation (HP:0002791) | 2.27301524 |
| 68 | Scanning speech (HP:0002168) | 2.25856928 |
| 69 | Spastic tetraplegia (HP:0002510) | 2.20907724 |
| 70 | Generalized myoclonic seizures (HP:0002123) | 2.19988446 |
| 71 | Status epilepticus (HP:0002133) | 2.18496590 |
| 72 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.13782091 |
| 73 | Stereotypic behavior (HP:0000733) | 2.12959022 |
| 74 | Gait imbalance (HP:0002141) | 2.12513778 |
| 75 | Amyotrophic lateral sclerosis (HP:0007354) | 2.11454720 |
| 76 | Blue irides (HP:0000635) | 2.08336611 |
| 77 | Craniofacial dystonia (HP:0012179) | 2.06558584 |
| 78 | Diminished movement (HP:0002374) | 2.06451694 |
| 79 | Lissencephaly (HP:0001339) | 2.04841011 |
| 80 | Intention tremor (HP:0002080) | 2.03960889 |
| 81 | Akinesia (HP:0002304) | 2.03704353 |
| 82 | Lower limb muscle weakness (HP:0007340) | 2.03347785 |
| 83 | Hemiplegia (HP:0002301) | 2.02908723 |
| 84 | Psychosis (HP:0000709) | 2.00742175 |
| 85 | Protruding tongue (HP:0010808) | 2.00734738 |
| 86 | Abnormality of the lower motor neuron (HP:0002366) | 1.99476967 |
| 87 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.98538026 |
| 88 | Abnormality of the labia minora (HP:0012880) | 1.98121291 |
| 89 | Rigidity (HP:0002063) | 1.96210870 |
| 90 | Gait ataxia (HP:0002066) | 1.94459696 |
| 91 | Specific learning disability (HP:0001328) | 1.94046349 |
| 92 | Abnormality of salivation (HP:0100755) | 1.91532621 |
| 93 | Hyperthyroidism (HP:0000836) | 1.90875803 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 1.90549771 |
| 95 | Abnormal hair whorl (HP:0010721) | 1.89849200 |
| 96 | Impaired vibratory sensation (HP:0002495) | 1.89740138 |
| 97 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89327866 |
| 98 | Ventricular fibrillation (HP:0001663) | 1.87502994 |
| 99 | Incomplete penetrance (HP:0003829) | 1.86835763 |
| 100 | Inappropriate behavior (HP:0000719) | 1.86401681 |
| 101 | Esotropia (HP:0000565) | 1.85997040 |
| 102 | Dysmetric saccades (HP:0000641) | 1.81794497 |
| 103 | Delusions (HP:0000746) | 1.81285383 |
| 104 | Megalencephaly (HP:0001355) | 1.80409502 |
| 105 | Exotropia (HP:0000577) | 1.79065091 |
| 106 | Pachygyria (HP:0001302) | 1.77436153 |
| 107 | Restlessness (HP:0000711) | 1.76578004 |
| 108 | Hypothermia (HP:0002045) | 1.76154558 |
| 109 | Poor suck (HP:0002033) | 1.74557205 |
| 110 | Medial flaring of the eyebrow (HP:0010747) | 1.74207872 |
| 111 | Prolonged QT interval (HP:0001657) | 1.74112138 |
| 112 | Postural tremor (HP:0002174) | 1.72722635 |
| 113 | Cerebral hypomyelination (HP:0006808) | 1.70863765 |
| 114 | Spastic tetraparesis (HP:0001285) | 1.69958244 |
| 115 | Dyskinesia (HP:0100660) | 1.68996115 |
| 116 | Congenital primary aphakia (HP:0007707) | 1.66262838 |
| 117 | Aqueductal stenosis (HP:0002410) | 1.65179901 |
| 118 | Clonus (HP:0002169) | 1.63140465 |
| 119 | Paraplegia (HP:0010550) | 1.63017600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.32974046 |
| 2 | MAP3K9 | 3.89663931 |
| 3 | MARK1 | 3.59254538 |
| 4 | MAP3K4 | 3.46778448 |
| 5 | EPHA4 | 3.32137993 |
| 6 | MAP3K12 | 3.08942239 |
| 7 | MAP2K7 | 3.07666302 |
| 8 | MINK1 | 2.74450788 |
| 9 | PNCK | 2.39987919 |
| 10 | CASK | 2.33534472 |
| 11 | NTRK2 | 2.32760093 |
| 12 | MAP2K4 | 2.27812235 |
| 13 | NTRK1 | 2.05426104 |
| 14 | PAK6 | 1.84168182 |
| 15 | DAPK2 | 1.80539366 |
| 16 | KSR2 | 1.69127664 |
| 17 | GRK5 | 1.67560194 |
| 18 | TNIK | 1.62678738 |
| 19 | FRK | 1.61516621 |
| 20 | DYRK2 | 1.60699140 |
| 21 | RIPK4 | 1.59016009 |
| 22 | MAPK13 | 1.56217936 |
| 23 | CDK5 | 1.51526064 |
| 24 | KSR1 | 1.50891482 |
| 25 | PLK2 | 1.49243932 |
| 26 | SIK2 | 1.47703143 |
| 27 | ARAF | 1.39716107 |
| 28 | DAPK1 | 1.34374196 |
| 29 | CAMKK1 | 1.31876540 |
| 30 | FES | 1.24368946 |
| 31 | PRKCG | 1.20844273 |
| 32 | CDK19 | 1.19500119 |
| 33 | CSNK1G2 | 1.19160362 |
| 34 | LATS2 | 1.17603005 |
| 35 | PRKD3 | 1.17550085 |
| 36 | UHMK1 | 1.16675467 |
| 37 | CAMK2A | 1.10727124 |
| 38 | PHKG2 | 1.09299342 |
| 39 | PHKG1 | 1.09299342 |
| 40 | FGFR2 | 1.07670867 |
| 41 | STK38 | 0.99578743 |
| 42 | CDK18 | 0.93451287 |
| 43 | MAP3K13 | 0.92588639 |
| 44 | CDK14 | 0.91322831 |
| 45 | CAMKK2 | 0.90879853 |
| 46 | CDK15 | 0.89952119 |
| 47 | CAMK2B | 0.87726073 |
| 48 | RET | 0.87415504 |
| 49 | PRPF4B | 0.86891300 |
| 50 | TRIM28 | 0.86326386 |
| 51 | MAP4K2 | 0.83420417 |
| 52 | MAP3K2 | 0.83389896 |
| 53 | TYRO3 | 0.83247938 |
| 54 | SGK494 | 0.81014135 |
| 55 | SGK223 | 0.81014135 |
| 56 | PAK3 | 0.80384177 |
| 57 | CDK11A | 0.78219477 |
| 58 | CSNK1G3 | 0.77139599 |
| 59 | STK11 | 0.75775254 |
| 60 | CAMK1 | 0.75492721 |
| 61 | OXSR1 | 0.74784380 |
| 62 | DYRK1A | 0.74021654 |
| 63 | NME1 | 0.71781831 |
| 64 | CSNK1A1L | 0.70798463 |
| 65 | SGK2 | 0.70006358 |
| 66 | GRK7 | 0.65944037 |
| 67 | PRKCH | 0.65898953 |
| 68 | SIK3 | 0.65151933 |
| 69 | CAMK1G | 0.64379931 |
| 70 | SGK1 | 0.62157733 |
| 71 | LMTK2 | 0.61914844 |
| 72 | PRKCE | 0.61764426 |
| 73 | WNK3 | 0.61716107 |
| 74 | MAPKAPK5 | 0.59561873 |
| 75 | CAMK2D | 0.59033872 |
| 76 | WNK4 | 0.58703550 |
| 77 | BMPR2 | 0.58623265 |
| 78 | RAF1 | 0.58498416 |
| 79 | MAP3K6 | 0.57756447 |
| 80 | PTK2B | 0.56831005 |
| 81 | TNK2 | 0.53178037 |
| 82 | FGR | 0.52751508 |
| 83 | STK39 | 0.51407863 |
| 84 | CAMK4 | 0.51114817 |
| 85 | PRKCZ | 0.50875063 |
| 86 | PINK1 | 0.49804210 |
| 87 | FER | 0.49002527 |
| 88 | CAMK2G | 0.48226729 |
| 89 | CSNK1D | 0.47921807 |
| 90 | SGK3 | 0.47717746 |
| 91 | AKT3 | 0.46179751 |
| 92 | MARK2 | 0.44757325 |
| 93 | FYN | 0.44625859 |
| 94 | MAP3K1 | 0.44318525 |
| 95 | MKNK2 | 0.43998782 |
| 96 | BCR | 0.43891130 |
| 97 | PRKG1 | 0.43325767 |
| 98 | RPS6KA3 | 0.42846251 |
| 99 | ALK | 0.42746283 |
| 100 | CSNK1E | 0.42338009 |
| 101 | PDK1 | 0.42039145 |
| 102 | TAOK1 | 0.41555947 |
| 103 | PRKACA | 0.39769607 |
| 104 | ADRBK2 | 0.39654491 |
| 105 | SCYL2 | 0.39621618 |
| 106 | CSNK1G1 | 0.39525044 |
| 107 | MAPK10 | 0.39025051 |
| 108 | WNK1 | 0.38968582 |
| 109 | PKN1 | 0.38965247 |
| 110 | PRKACB | 0.38828122 |
| 111 | ROCK2 | 0.38539963 |
| 112 | MAP2K1 | 0.38532584 |
| 113 | ERBB4 | 0.38295639 |
| 114 | ERBB3 | 0.37952006 |
| 115 | ADRBK1 | 0.37745884 |
| 116 | INSRR | 0.37437317 |
| 117 | GRK1 | 0.37155824 |
| 118 | CSNK1A1 | 0.33645982 |
| 119 | PRKCB | 0.32120677 |
| 120 | MAPK12 | 0.31889054 |
| 121 | MAP2K6 | 0.29595679 |
| 122 | PRKCA | 0.29567171 |
| 123 | LIMK1 | 0.26808815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.14903443 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.79051412 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.89221886 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.79358081 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.55702453 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53523212 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51796706 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.51553925 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.49854259 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.46124984 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.32130149 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.17344584 |
| 13 | Cocaine addiction_Homo sapiens_hsa05030 | 2.09909128 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.06178652 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.02136698 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.94182390 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92220974 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.91672611 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91516928 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.74068421 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72787096 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.63910994 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.62892228 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.55727659 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54196840 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53697506 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.48124518 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.34711495 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32634950 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31197063 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28452187 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27838486 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24880861 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18707945 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14319655 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13630050 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11140030 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10516764 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.09917186 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09036495 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05427583 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03700075 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00535943 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99664650 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97912288 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95926028 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.95018029 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94935346 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94407022 |
| 50 | Glioma_Homo sapiens_hsa05214 | 0.93234983 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.88242509 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85621488 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85354967 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83835187 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81796106 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77924885 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76099116 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73548458 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71073752 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68970153 |
| 61 | Alcoholism_Homo sapiens_hsa05034 | 0.67181800 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62371408 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61851661 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61469185 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58227061 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57850524 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54435962 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53432492 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53044981 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52920434 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52285388 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50100365 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49633221 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49613059 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47662004 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46967768 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45334189 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44607400 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44249070 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43803563 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42961100 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42833158 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42465304 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40865684 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.39905803 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38251117 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.38031890 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37431472 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.36620852 |
| 90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36341855 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36256524 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35730717 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35715378 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35066514 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.34075178 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.33383310 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33355157 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32895273 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32891909 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.32680048 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32662110 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.30253718 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29793400 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29633372 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28590530 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28557484 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28557099 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28342839 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28275420 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.27276043 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.25591914 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25302311 |
| 113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.24989919 |
| 114 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23389427 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20679012 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19633277 |

